PHAGEPY

International nonproprietary name: Bacteriophagum Pyocyaneum Liquidum

Description: Various intensity, yellow, transparent, specific taste liquid

Qualitative and Quantitative Composition:
Active ingredient
Mixture of sterile filtrates of bacterial phagelysates of - Pseudomonas aeruginosa.

Quantitative composition
1 ml preparation contains Pseudomonas aeruginosa bacteria specific phages - Bacteriophagum Pseudomonas aeruginosa - not less than 105;

Pharmaceutical form: Sterile liquid in 20 ml bottles, for oral administration, local and external use.

Pharmacotherapeutical category: Specific antibacterial product.

ATC Code: J01XX

Pharmacological actions: Bacteriophage is specific bacterial viruses, which is adsorbed on the homological bacterial cell membrane, penetrates into the cell, multiplies and causes its lyses.

The composition of PHAGEPY is selective, only virulent phages of bacteria - Pseudomonas aeruginosa, which ensures a high activity and effectiveness of the bacteriophage products.

Antibacterial efficacy of bacteriophage products is based on specific lysis ability of pathogenic bacteria in nidus of infection under exposure of bacteriophages. Despite the mode of introduction, bacteriophage products enter the blood and lymph and enter into the nidus of infection and the main part of medicinal product excreted by kidney and the rest by gastrointestinal tract. In addition the medicinal product stimulates activity of patient immune system and is efficient in treatment of diarrheal diseases of immunocompromised patients.

Bacteriophage is bacterial virus which enters bacterial cell, multiplies in cell, causing cell rupture and yielding new mature bacteriophage particles ready to infect new bacterial cells. Bacteriophages are strictly specific towards homological bacteria and therefore don't suppress human normal flora and are absolutely safe for human cells.